RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VAVALà T
Collezione AOU San Luigi di Orbassano

Items : 19

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Jan;187:107444. doi: 10.1016/j.lungcan.2023.107444. Epub 2023 Dec 15.

2024
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Malapelle U; Novello S; Garbo E; Agustoni F; Gori S; Grisanti S; Catania C; Buffoni L; Buosi R; Brambilla M; Vavalà T; Scotti V; Carta A; Cerea G; Tiseo M; Delmonte A; Russo A; Cortinovis D; Chiari R; Metro G; Citarella F; Genova C; Roca E; Pilotto S; Bria E; Pelizzari G; Sini C; Galetta D; Bulotta A; et alii...

The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer. in JTO clinical and research reports / JTO Clin Res Rep. 2021 May 24;2(7):100194. doi: 10.1016/j.jtocrr.2021.100194. eCollection 2021 Jul.

2021
AOU San Luigi di Orbassano

Gitlitz BJ; Novello S; Vavalà T; Bittoni M; Sable-Hunt A; Pavlick D; Hsu R; Park SL; Chen R; Cooke M; Moore A; Schrock AB; Schiller JH; Addario BJ; Oxnard GR;

An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease. in Respirology (Carlton, Vic.) / Respirology. 2020 Nov;25 Suppl 2:24-36. doi: 10.1111/resp.13965. Epub 2020 Oct 29.

2020
AOU San Luigi di Orbassano

Vavalà T; Rigney M; Reale ML; Novello S; King JC;

Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. in Future oncology (London, England) / Future Oncol. 2019 Mar;15(9):989-994. doi: 10.2217/fon-2018-0469. Epub 2019 Jan 25.

2019
AOU San Luigi di Orbassano

Abbate MI; Cortinovis DL; Tiseo M; Vavalà T; Cerea G; Toschi L; Canova S; Colonese F; Bidoli P;

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer. in Translational cancer research / Transl Cancer Res. 2019 Jan;8(Suppl 1):S48-S54. doi: 10.21037/tcr.2018.10.23.

2019
ASL Cuneo 1
AOU San Luigi di Orbassano

Novello S; Mariniello A; Vavalà T;

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer. in Frontiers in oncology / Front Oncol. 2018 Jul 27;8:278. doi: 10.3389/fonc.2018.00278. eCollection 2018.

2018
ASL Cuneo 1
AOU San Luigi di Orbassano

Novello S; Vavalà T; Morelli AM; Turkaj A;

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2018 Aug 3;10:1758835918789364. doi: 10.1177/1758835918789364. eCollection 2018.

2018
ASL Cuneo 1
AOU San Luigi di Orbassano

Vavalà T; Novello S;

Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 May;107:84-90. doi: 10.1016/j.lungcan.2016.05.021. Epub 2016 May 31.

2017
AOU San Luigi di Orbassano

Vavalà T; Monica V; Lo Iacono M; Mele T; Busso S; Righi L; Papotti M; Scagliotti GV; Novello S;

Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward? in Current treatment options in oncology / Curr Treat Options Oncol. 2016 Oct;17(10):54. doi: 10.1007/s11864-016-0429-x.

2016
ASL Cuneo 1
AOU San Luigi di Orbassano

Novello S; Vavalà T; Buffoni L;

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.

2016
AOU San Luigi di Orbassano

Vavalà T; Follador A; Tiseo M; Galetta D; Morabito A; Di Maio M; Martelli O; Caffo O; Piovano PL; Cortinovis D; Zilembo N; Casartelli C; Banna GL; Ardizzoia A; Barzelloni ML; Bearz A; Genestreti G; Mucciarini C; Filipazzi V; Menis J; Rizzo E; Barbieri F; Rijavec E; Cecere F; Bria E; Spitaleri G; Rossi A; Novello S;

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study. in Targeted oncology / Target Oncol. 2016 Apr;11(2):157-66. doi: 10.1007/s11523-015-0383-8.

2016
AOU San Luigi di Orbassano

Vatrano S; Righi L; Vavalá T; Rapa I; Busso M; Izzo S; Cappia S; Veltri A; Papotti M; Scagliotti GV; Novello S;

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.

2015
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma. in Oncotarget / Oncotarget. 2015 May 20;6(14):12783-95. doi: 10.18632/oncotarget.3727.

2015
AOU San Luigi di Orbassano

Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;

ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. in International journal of cancer / Int J Cancer. 2015 Jun 1;136(11):2598-609. doi: 10.1002/ijc.29302. Epub 2014 Nov 12.

2015
AOU San Luigi di Orbassano

Lo Iacono M; Monica V; Vavalà T; Gisabella M; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV;

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 Oct;9(10):1540-6. doi: 10.1097/JTO.0000000000000271.

2014
AOU San Luigi di Orbassano

Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M;

Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. in Clinical lung cancer / Clin Lung Cancer. 2013 May;14(3):230-7. doi: 10.1016/j.cllc.2012.10.004. Epub 2012 Dec 29.

2013
AOU San Luigi di Orbassano

Novello S; Vavalà T; Levra MG; Solitro F; Pelosi E; Veltri A; Scagliotti GV;

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: a review of existing evidence. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2012 Aug;83(2):208-15. doi: 10.1016/j.critrevonc.2011.09.009. Epub 2011 Nov

2012
AOU San Luigi di Orbassano

Novello S; Giaj Levra M; Vavalà T;

Maintenance therapy in NSCLC: why? To whom? Which agent? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2011 May 6;30(1):50. doi: 10.1186/1756-9966-30-50.

2011
AOU San Luigi di Orbassano

Novello S; Milella M; Tiseo M; Banna G; Cortinovis D; Di Maio M; Garassino M; Maione P; Martelli O; Vavalà T; Bria E;

Lung cancer and women. in Future oncology (London, England) / Future Oncol. 2008 Oct;4(5):705-16. doi: 10.2217/14796694.4.5.705.

2008
AOU San Luigi di Orbassano

Novello S; Vavalà T;